Cell MedX Corp. (CMXC)
Cell MedX Corp. operates in the Medical - Devices industry of the Healthcare sector, headquartered in Carson City, NV, US. The stock last traded at $0.42, giving a market capitalisation of $126.3M. On trailing twelve-month figures it carries a trailing P/E of -11.01, a net margin of 0.0%. Its beta of -0.75 implies it has historically moved less than the broad market.
Cell MedX Corp. is a biotechnology firm dedicated to identifying, developing, and marketing both therapeutic and non-therapeutic solutions aimed at individuals suffering from conditions such as diabetes, Parkinson's disease, hypertension, neuropathy, and various kidney-related ailments. The company's offerings include the eBalance Pro System, designed for clinical application by medical professionals, and the eBalance Home System, intended for personal use to promote general well-being and alleviate pain. Both systems are managed by the eBalance Console, a central control unit featuring three distinct pre-programmed microcurrent algorithms: wellness, pain management, and a dual mode. Originally established in 2010 as Sports Asylum, Inc., the company adopted its current name, Cell MedX Corp., in September 2014. Its operations are headquartered in Carson City, Nevada.
Cell MedX Corp. is most often compared with the following Healthcare names: